Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Temel Yilmaz is active.

Publication


Featured researches published by Temel Yilmaz.


Hormone and Metabolic Research | 2010

Take Action to Prevent Diabetes – The IMAGE Toolkit for the Prevention of Type 2 Diabetes in Europe

Jaana Lindström; A. Neumann; Kate Sheppard; Aleksandra Gilis-Januszewska; Colin J Greaves; U. Handke; P. Pajunen; S. Puhl; A. Pölönen; Aila Rissanen; Michael Roden; T. Stemper; V. Telle-Hjellset; J. Tuomilehto; D. Velickiene; Peter Schwarz; Tania Acosta; Martin Adler; A. AlKerwi; Noël C. Barengo; R. Barengo; Jm Boavida; K. Charlesworth; V. Christov; B. Claussen; X. Cos; E Cosson; S. Deceukelier; V. Dimitrijevic-Sreckovic; Pb Djordjevic

When we ask people what they value most, health is usually top of the list. While effective care is available for many chronic diseases, the fact remains that for the patient, the tax payer and the whole of society: prevention is better than cure. Diabetes and its complications are a serious threat to the survival and well-being of an increasing number of people. It is predicted that one in ten Europeans aged 20-79 will have developed diabetes by 2030. Once a disease of old age, diabetes is now common among adults of all ages and is beginning to affect adolescents and even children. Diabetes accounts for up to 18 % of total healthcare expenditure in Europe. The good news is that diabetes is preventable. Compelling evidence shows that the onset of diabetes can be prevented or delayed greatly in individuals at high risk (people with impaired glucose regulation). Clinical research has shown a reduction in risk of developing diabetes of over 50 % following relatively modest changes in lifestyle that include adopting a healthy diet, increasing physical activity, and maintaining a healthy body weight. These results have since been reproduced in real-world prevention programmes. Even a delay of a few years in the progression to diabetes is expected to reduce diabetes-related complications, such as heart, kidney and eye disease and, consequently, to reduce the cost to society. A comprehensive approach to diabetes prevention should combine population based primary prevention with programmes targeted at those who are at high risk. This approach should take account of the local circumstances and diversity within modern society (e.g. social inequalities). The challenge goes beyond the healthcare system. We need to encourage collaboration across many different sectors: education providers, non-governmental organisations, the food industry, the media, urban planners and politicians all have a very important role to play. Small changes in lifestyle will bring big changes in health. Through joint efforts, more people will be reached. The time to act is now.


BioMed Research International | 2009

Salivary glucose concentration and excretion in normal and diabetic subjects

Cédric Jurysta; Nurdan Bulur; Berrin Oguzhan; Ilhan Satman; Temel Yilmaz; Willy Malaisse; Abdullah Sener

The present report aims mainly at a reevaluation of salivary glucose concentration and excretion in unstimulated and mechanically stimulated saliva in both normal and diabetic subjects. In normal subjects, a decrease in saliva glucose concentration, an increase in salivary flow, but an unchanged glucose excretion rate were recorded when comparing stimulated saliva to unstimulated saliva. In diabetic patients, an increase in salivary flow with unchanged salivary glucose concentration and glucose excretion rate were observed under the same experimental conditions. Salivary glucose concentration and excretion were much higher in diabetic patients than in control subjects, whether in unstimulated or stimulated saliva. No significant correlation between glycemia and either glucose concentration or glucose excretion rate was found in the diabetic patients, whether in unstimulated or stimulated saliva. In the latter patients, as compared to control subjects, the relative magnitude of the increase in saliva glucose concentration was comparable, however, to that of blood glucose concentration. The relationship between these two variables was also documented in normal subjects and diabetic patients undergoing an oral glucose tolerance test.


BMJ open diabetes research & care | 2015

Recommendations for management of diabetes during Ramadan: update 2015

Mahmoud Ibrahim; Megahed Abu Al Magd; Firas A Annabi; Samir Assaad-Khalil; Ebtesam M Ba-Essa; Ibtihal Fahdil; Sehnaz Karadeniz; Terry Meriden; Aly A Misha'l; Paolo Pozzilli; Samad Shera; Abraham Thomas; Suhad Bahijri; Jaakko Tuomilehto; Temel Yilmaz; Guillermo E. Umpierrez

Since the first ADA working group report on the recommendations for management of diabetes during Ramadan in 2005 and our update in 2010, we received many inquiries asking for regular updates on information regarding education, nutritional habits and new oral and injectable agents that may be useful for the management of patients with diabetes during Ramadan. Patients can be stratified into their risk of hypoglycemia and/or complications prior to the start of the fasting period of Ramadan. Those at high risk of hypoglycemia and with multiple diabetic complications should be advised against prolonged fasting. Even in the lower hypoglycemia risk group, adverse effects may still occur. In order to minimize adverse side effects during fasting in patients with diabetes and improve or maintain glucose control, education and discussion of glucose monitoring and treatment regimens should occur several weeks prior to Ramadan. Agents such as metformin, thiazolidinediones and dipeptidyl peptidase-4 inhibitors appear to be safe and do not need dose adjustment. Most sulfonylureas may not be used safely during Ramadan except with extreme caution; besides, older agents, such as chlorpropamide or glyburide, should not be used. Reduction of the dosage of sulfonylurea is needed depending on the degree of control prior to fasting. Misconceptions and local habits should be addressed and dealt with in any educational intervention and therapeutic planning with patients with diabetes. In this regard, efforts are still needed for controlled prospective studies in the field of efficacy and safety of the different interventions during the Ramadan Fast.


Fertility and Sterility | 2000

Influence of insulin resistance on total renin level in normotensive women with polycystic ovary syndrome

Burak Hacıhanefioglu; Hakan Seyisoglu; Kubilay Karsidag; Koray Elter; Feridun Aksu; Temel Yilmaz; Ali Osman Gurol

OBJECTIVE To evaluate the influence of insulin resistance on the plasma total renin level in normotensive women with polycystic ovary syndrome (PCOS). DESIGN Prospective, controlled study. SETTING University hospital. PATIENT(S) Twenty-five normotensive women with PCOS were compared with 11 normotensive control women with regular cycles and no features of PCOS. INTERVENTION(S) Clinical, ultrasonographic, and hormonal findings were used to define PCOS. Insulin resistance was estimated by continuous infusion of glucose with model assessment in the early follicular phase. MAIN OUTCOME MEASURE(S) Plasma levels of total renin and angiotensin II and serum levels of gonadotropins, DHEAS, total T, free T, 17 alpha-hydroxyprogesterone, and PRL were determined. RESULT(S) Plasma concentrations of angiotensin II were similar in the PCOS group and the control group. The concentration of total renin in plasma was higher in women with PCOS than in healthy women independent of insulin resistance. The sensitivity and specificity of the plasma total renin level to diagnose women with PCOS were calculated as 80% and 71.4%, respectively. CONCLUSION(S) The plasma total renin level is higher in normotensive women with PCOS than in healthy women independent of insulin resistance.


Patient Education and Counseling | 2003

Diabetes education: a chance to improve well-being of Turkish people with type 2 diabetes

Emel Özer; Ahmet M. Şengül; Selda Gedik; Serpil Salman; Fatih Salman; Mehmet Sargin; Halim Issever; Ilhan Satman; Temel Yilmaz

To examine the influence of diabetes education on well-being, 255 patients with type 2 diabetes were recruited according to whether they attended a diabetes education program (n=126) or not (n=129). In patients who had participated in the program, the mean anxiety score was significantly lower, whereas positive well-being and general well-being scores were significantly higher than for patients who had not participated. Factors related to lower well-being included: being female, taking insulin, not attending a diabetes education program and having HbA(1c) level greater than 8%. The odds of having better well-being were two-fold higher in patients participating the diabetes education program compared with those who had not. Diabetes education has a crucial role in improving the well-being of patients with type 2 diabetes. All patients with diabetes should be encouraged to attend a diabetes education program.


Diabetes Care | 2002

Population-Based Study of Diabetes and Risk Characteristics in Turkey Results of the Turkish Diabetes Epidemiology Study (TURDEP)

Ilhan Satman; Temel Yilmaz; Ahmet Sengül; Serpil Salman; Fatih Salman; Sevil Uygur; Irfan Bastar; Yildiz Tutuncu; Mehmet Sargin; Nevin Dinccag; Kubilay Karsidag; Sibel Kalaça; Cihangir Özcan; Hilary King


European Journal of Epidemiology | 2013

Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults

Ilhan Satman; Beyhan Omer; Yildiz Tutuncu; Sibel Kalaça; Selda Gedik; Nevin Dinccag; Kubilay Karsidag; Sema Genc; Aysegul Telci; Bulent Canbaz; Fulya Turker; Temel Yilmaz; Bekir Cakir; Jaakko Tuomilehto


Endocrine Journal | 2004

Lessons Learnt from Influences of the Marmara Earthquake on Glycemic Control and Quality of Life in People with Type 1 Diabetes

Ahmet Sengül; Emel Özer; Serpil Salman; Fatih Salman; Zuhal Saglam; Mehmet Sargin; Sukru Hatun; Ilhan Satman; Temel Yilmaz


Diabetes Research and Clinical Practice | 2005

Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study

Paolo Pozzilli; Silvia Manfrini; Raffaella Buzzetti; E. Lampeter; I. De Leeuw; Dario Iafusco; M Prisco; Constantin Ionescu-Tirgoviste; S. Kolouskova; Thomas Linn; Johnny Ludvigsson; László Madácsy; A Seremak Mrozikiewicz; P M Mrozikiewicz; T. Podar; J. Vavrinec; B Vialettes; Natalia Visalli; Temel Yilmaz; Pd Browne


Journal of Oral Science | 2001

Alstrom syndrome : a case report

Fatma Koray; Can Dörter; Yasemin Benderli; Ilhan Satman; Temel Yilmaz; Nevin Dinccag; Kubilay Karsidag

Collaboration


Dive into the Temel Yilmaz's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge